Markiewicz et al., [38] found that CTC-enriched HER2-positive (mRNA) blood samples from lymph node positive BC patients were 100% positive for PLAUR mRNA expression compared to 34% of HER2 negative samples. This evidence concerns the gene ERBB2 and breast cancer.